Baillie Gifford & Co
AMED

Baillie Gifford & Co’s Amedisys AMED Stock Holding History

Baillie Gifford & Co’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,829
Closed -$297K – 186
2015
Q3 		$297K Sell
7,829
-2,100
-21% -$88.6K ﹤0.01% 192
2015
Q2 		$394K Sell
9,929
-2,900
-23% -$90.4K ﹤0.01% 188
2015
Q1 		$344K Hold
12,829
– – ﹤0.01% 192
2014
Q4 		$377K Sell
12,829
-6,300
-33% -$156K ﹤0.01% 192
2014
Q3 		$386K Hold
19,129
– – ﹤0.01% 193
2014
Q2 		$320K Hold
19,129
– – ﹤0.01% 192
2014
Q1 		$285K Hold
19,129
– – ﹤0.01% 194
2013
Q4 		$280K Hold
19,129
– – ﹤0.01% 196
2013
Q3 		$329K Hold
19,129
– – ﹤0.01% 183
2013
Q2 		$222K Buy
+19,129
New +$219K ﹤0.01% 168

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Baillie Gifford & Co's AMED Position: Q4 2015 in Review

Baillie Gifford & Co sold out of Amedisys (AMED) in Q4 2015, closing a stake of 7,829 shares — an estimated $297K sold.

Baillie Gifford & Co first reported a position in AMED in Q2 2013 and held it in 10 quarters. The position peaked at $394K in Q2 2015. 165 funds tracked by Wall St. Rank hold AMED as of Q4 2015.

  • Baillie Gifford & Co reported no remaining Amedisys position as of Q4 2015 after selling out during the quarter.
  • Baillie Gifford & Co sold 7,829 Amedisys shares in Q4 2015, an estimated $297K.
  • Baillie Gifford & Co first reported a position in Amedisys in Q2 2013 and held it in 10 quarters.
  • Baillie Gifford & Co's Amedisys position peaked at $394K in Q2 2015.
  • 165 funds tracked by Wall St. Rank held Amedisys as of Q4 2015.

Based on Baillie Gifford & Co's 13F filing for Q4 2015, filed 8 Feb 2016.